NuPotential
About:
NuPotential produces cell lines suitable for re-differentiation into multiple lineages and somatic cell nuclear transfers.
Website: http://nupotential.com
Description:
NuPotential produces dedifferentiated cell lines suitable for re-differentiation into multiple lineages and somatic cell nuclear transfer. Its cells are used in therapies that reverse the debilitating effects of diabetes, stroke, heart disease, Alzheimer's disease, Parkinson's disease, and other afflictions, as well as in drug discovery tool applications.
Total Funding Amount:
$725000
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Baton Rouge, Louisiana, United States
Founded Date:
2004-01-01
Founders:
Kenneth Eilertsen
Number of Employees:
1-10
Last Funding Date:
2014-03-05
IPO Status:
Private
Industries:
© 2025 bioDAO.ai